A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1613127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2008English

Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2013English

Immunogenicity and Safety of an Egg-Based Inactivated Quadrivalent Influenza Vaccine (GC3110A) Versus Two Inactivated Trivalent Influenza Vaccines With Alternate B Strains: A Phase Ⅲ Randomized Clinical Trial in Adults

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Safety and Immunogenicity of the rVSV∆G-ZEBOV-GP Ebola Virus Vaccine Candidate in Healthy Adults: A Phase 1b Randomised, Multicentre, Double-Blind, Placebo-Controlled, Dose-Response Study

The Lancet Infectious Diseases
Infectious Diseases
2017English

Safety and Immunogenicity of a Recombinant Adenovirus Type-5 Vector-Based Ebola Vaccine in Healthy Adults in Sierra Leone: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

The Lancet
Medicine
2017English

Immunogenicity and Reactogenicity of High- Versus Standard-Dose Trivalent Inactivated Influenza Vaccine in Healthcare Workers: A Pilot Randomized Controlled Trial

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

A Phase I, Placebo-Controlled, Randomized, Double-Blind, Single Ascending Dose-Ranging Study to Evaluate the Safety and Tolerability of a Novel Biophysical Bronchodilator (S-1226) Administered by Nebulization in Healthy Volunteers

Trials
MedicinePharmacology
2016English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy